What is the impact of resistance to activated protein C (Leiden mutation to factor V) in inflammatory bowel disease?

International Journal of Colorectal Disease

Volumn 21, Issue 7, 2006, Pages 705-710

  Attvall, Emma ^a   Frigyesi, Attila ^a   Sternby, Berit ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

APC resistance; Crohn's disease; FactorV Leiden mutation; IBD; Ulcerative colitis

Indexed keywords

ACTIVATED PROTEIN C; BLOOD CLOTTING FACTOR 5;

ACTIVATED PROTEIN C RESISTANCE; ADULT; AGED; ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; CROHN DISEASE; DISEASE ASSOCIATION; ENTERITIS; FEMALE; GASTROINTESTINAL SURGERY; GENE MUTATION; HUMAN; INFORMED CONSENT; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PRIORITY JOURNAL; QUESTIONNAIRE; RISK ASSESSMENT; SELF REPORT; THROMBOSIS; ULCERATIVE COLITIS;

ACTIVATED PROTEIN C RESISTANCE; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ALCOHOL DRINKING; BODY MASS INDEX; COLITIS, ULCERATIVE; CROHN DISEASE; DIABETES COMPLICATIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; TOBACCO;

EID: 33748997394     PISSN: 01791958     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00384-005-0067-4     Document Type: Article

References (34)

1. Dahlbäck B, Carlsson M, Svensson PJ (1993) Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: Prediction of a cofactor to activated protein C. Proc Natl Acad Sci U S A 90:1004-1008
2. Dahlbäck B (1997) Resistance to activated protein C as a risk factor for thrombosis: Molecular mechanism, laboratory investigation and clinical management. Semin Hematol 34:217-234
3. Hillarp A, Zöller B, Dahlbäck B (1996) Activated protein C resistance as a basis for venous thrombosis. Am J Med 101:534-540
4. Zöller B, Norlund L, Leksell H, Nilsson J-E, von Schenck H, Rosen U, Jepsson JO, Dahlbäck B (1996) High prevalence of the FVR506Q mutation causing APCR in a region of southern Sweden with a high incidence of venous thrombosis. Thromb Res 83:475-477
5. Jackson LM, O'Gorma PJ, O'Connell J, Cronin CC, Cotter KP, Shanahan F (1997) Thrombosis in inflammatory bowel disease: Clinical setting, procoagulant profile and factor V Leiden. QJM 90:183-188
6. Zauber NP, Sabbath-Solitare M, Rajoria G, Mogan G (1998) Factor V Leiden mutation is not increased in patients with inflammatory bowel disease. J Clin Gastroenterol 27:215-216
7. Liebman HA, Kashani N, Sutherland D, McGehee W, Kam AL (1998) The factor V Leiden mutation increases the risk of venous thrombosis in patients with IBD. Gastroenterology 115:830-834
8. Heneghan M, Cleary B, Murray M, O'Gorman TA, Mc Carthy CF (1998) Activated protein C resistance, thrombophilia and IBD. Dig Dis Sci 43:1356-1361
9. Novacek G, Miehsler W, Kapiotis S, Katzenschlager R, Speiser W (1999) Thromboembolism and resistance to activated protein C in patients with IBD. Am J Gastroenterol 94:685-690
10. Helio T, Wartiovaara U, Halme L, Turunen H, Mikkola H, Palotie A (1999) Farkkila M, Kontula K. Arg506Gln Factor V mutation and val34Leu Factor XIII polymorphism in Finnish patients with IBD. Scand J Gastroenterol 34:170-171
11. Haslam N, Standen GR, Probert CS (1999) An investigation of the association of the factor V Leiden mutation and inflammatory bowel disease. Eur J Gastroenterol Hepatol 11:1289-1291
12. Vecchi M, Sacchi E, Saibeni S, Meucci Gl, Tagliabue L, Duca F, De Franchis R (2000) IBD are not associated with major hereditary conditions predisposing to thrombosis. Dig Dis Sci 45:1465-1469
13. Koutroubakis IE, Sfiridaki A, Mouzas IA, Maldaki A, Kapsoritakis AN, Roussomoustakaki M, Kouroumalis EA, Manousos ON (2000) Resistance to activated protein C and low levels of free protein S in Greek patients with IBD. Am J Gastroenterol 95:190-194
14. Sundaram KK, Cotton R, Hart P, Jones L, Gould SR (2000) Laboratory findings associated with thrombophilia are not more common in inflammatory bowel disease. Clin Lab Haematol 22:243-245
15. Papa A, De Stefano V, Gasbarrini A, Chiusolo P, Cinanci P, Casorelli I, Paciaroni K, Cammarota G, Leone G, Gasbarrini G (2000) Prevalence of factor V Leiden and the G20210A prothrombotic gene mutation in inflammatory bowel disease. Blood Coagul Fibrinolysis 11:499-503
16. Guédion C, Le Cam-Duchez V, Lalaude O, Ménard JF, Lerebours E, Borg JY (2001) Prothrombotic inherited abnormalities other than factor V Leiden mutation do not play a role in venous thrombosis in IBD. Am J Gastroenterol 96:1448-1454
17. Nagy Z, Nagy A, Karadi O, Figler M, Runi G Jr, Suto G, Vincze A, Par A, Mozsik G (2001) Prevalence of the factor V Leiden mutation in human inflammatory bowel disease with different activity. J Physiol Paris 95:483-487
18. Turri D, Rosselli M, Simioni P, Tormene D, Grimaudo S, Martorana G, Siragusa S, Mariani G, Cottone M, Siracusa S (2001) Factor V Leiden and prothrombin gene mutation in inflammatory bowel disease in a Mediterranean area. Dig Liver Dis 33:559-562
19. Kader HA, Berman WF, Al-Seraihy AS, Ware RE, Ulshen MH, Treem WR (2002) Prevalence of factor V G1691A (Leiden), prothrombin G20210A, and methylene tetrahydrofolate reductase C6771T thrombophilic mutations in children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 35:629-635
20. Dahlbäck B, Stenflo J (1994) The protein C anticoagulantia system. In: Stamatoyannopoulos G, Nienuis AW, Majerus PW et al (eds) The molecular mechanism of blood diseases. Saunders, Philadelphia, PA, pp 599-628
21. Dahlbäck B (1995) The protein C anticoagulantia system: Inherited defects as a basis for venous thrombosis. Thromb Res 77:1-43
22. Wright M, Goldin R, Hellier S, Knapp S, Frodsham A, Henning B, Hill A, Apple R, Cheng S, Thomas H, Thursz M (2003) Factor V Leiden polymorphism and rate of fibrosis development in chronic hepatitis C virus infection. Gut 52:1206-1210
23. Graef V, Baggentoss AH, Sauer WG, Spittel JA Jr (1966) Venous thrombosis occurring in non-specific ulcerative colitis. Arch Intern Med 117:377-382
24. Grip O, Svensson PJ, Lindgren S (2000) IBD promotes thrombosis earlier in life. Scand J Gastroenterol 35:619-623
25. Ricketts W, Palmer S (1946) Complications of chronic non-specific ulcerative colitis. Gastroenterology 7:55-56
26. Edwards FC, Truelove SC (1964) The course and prognosis of ulcerative colitis. III. Complications. Gut 5:1-22
27. Bargen JA, Barker NW (1936) Extensive arterial and venous thrombosis complicating chronic ulcerative colitis. Arch Intern Med 58:17-31
28. Talbot R, Heppel J, Dozois R, Beart R (1986) Vascular complications of IBD. Mayo Clin Proc 61:140-145
29. Conlan MG, Haire WD, Burnett DA (1989) Prothrombotic abnormalities in IBD. Dig Dis Sci 34:1089-1093
30. Lam A, Borda IT, Inwood MJ, Thomson S (1975) Coagulation studies in ulcerative colitis and Crohn's disease. Gastroenterology 68:245-251
31. Lake AM, Stauffer JQ, Stuart MJ (1978) Hemostatic alterations in IBD. Response to therapy. Am J Dig Dis 23:897-902
32. Ang YS, Mahmud N, White B, Byrne M, Kelly A, Lamber M, McDonalds GS, Smith CP, Kelling PW (2000) Randomized comparison of unfractionated heparin with corticosteroids in severe active IBD. Aliment Pharmacol Ther 14:1015-1022
33. Törkvist L, Thorlacius H, Sjöqvist U, Bohman L, Lapidus A, Flood L, Agren B, Rand J, Lofberg R (1999) Low molecular weight heparin as adjuvant therapy in active ulcerative colitis. Aliment Pharmacol Ther 13:1323-1328
34. Xu Z, Westrick RJ, Shen YC, Eitzman DT (2001) Pulmonary fibrosis is increased in mice carrying the factor V Leiden mutation following bleomycin injury. Thromb Haemost 85:441-444